-
IntroducedJul 21, 2026
-
Passed Senate
-
Passed House
-
Became Law
United States Senate Bill
A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.
Last Action See all actions
Senate • Jul 21, 2026: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Summary
Comments on S 5059
Tweets
Whip Lists
Sponsors


- Sen. Blunt Rochester, Lisacosponsor
Votes
Actions
- Jul 21, 2026 | Senate
- Introduced in Senate
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Bill Texts
Documents
